Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Corrigendum to 'Drug metabolism and pharmacokinetic strategies for oligonucleotide- and mRNA-based drug development' Drug Discovery Today 23 (2018) 1733-1745.

Andersson S, Antonsson M, Elebring M, Jansson-Löfmark R, Weidolf L.

Drug Discov Today. 2019 Sep;24(9):1953. doi: 10.1016/j.drudis.2018.11.025. Epub 2018 Dec 7. No abstract available.

PMID:
30529076
2.

A Versatile and Convenient Synthesis of 34 S-Labeled Phosphorothioate Oligonucleotides.

Stulz R, Meuller J, Baždarević D, Wennberg Huldt C, Strömberg R, Andersson S, Dahlén A.

Chembiochem. 2018 Oct 4;19(19):2114-2119. doi: 10.1002/cbic.201800417. Epub 2018 Sep 13.

3.

Drug metabolism and pharmacokinetic strategies for oligonucleotide- and mRNA-based drug development.

Andersson S, Antonsson M, Elebring M, Jansson-Löfmark R, Weidolf L.

Drug Discov Today. 2018 Oct;23(10):1733-1745. doi: 10.1016/j.drudis.2018.05.030. Epub 2018 May 28. Review. Erratum in: Drug Discov Today. 2018 Dec 7;:.

PMID:
29852223
4.

Impact of body weight, low energy diet and gastric bypass on drug bioavailability, cardiovascular risk factors and metabolic biomarkers: protocol for an open, non-randomised, three-armed single centre study (COCKTAIL).

Hjelmesæth J, Åsberg A, Andersson S, Sandbu R, Robertsen I, Johnson LK, Angeles PC, Hertel JK, Skovlund E, Heijer M, Ek AL, Krogstad V, Karlsen TI, Christensen H, Andersson TB, Karlsson C.

BMJ Open. 2018 May 29;8(5):e021878. doi: 10.1136/bmjopen-2018-021878.

5.

The Conundrum of GSK3 Inhibitors: Is it the Dawn of a New Beginning?

Bhat RV, Andersson U, Andersson S, Knerr L, Bauer U, Sundgren-Andersson AK.

J Alzheimers Dis. 2018;64(s1):S547-S554. doi: 10.3233/JAD-179934. Review.

PMID:
29758944
6.

Publisher Correction: Functional coupling of human pancreatic islets and liver spheroids on-a-chip: Towards a novel human ex vivo type 2 diabetes model.

Bauer S, Wennberg Huldt C, Kanebratt KP, Durieux I, Gunne D, Andersson S, Ewart L, Haynes WG, Maschmeyer I, Winter A, Ämmälä C, Marx U, Andersson TB.

Sci Rep. 2018 Jan 23;8(1):1672. doi: 10.1038/s41598-018-20340-1.

7.

Functional coupling of human pancreatic islets and liver spheroids on-a-chip: Towards a novel human ex vivo type 2 diabetes model.

Bauer S, Wennberg Huldt C, Kanebratt KP, Durieux I, Gunne D, Andersson S, Ewart L, Haynes WG, Maschmeyer I, Winter A, Ämmälä C, Marx U, Andersson TB.

Sci Rep. 2017 Nov 6;7(1):14620. doi: 10.1038/s41598-017-14815-w. Erratum in: Sci Rep. 2018 Jan 23;8(1):1672.

8.

Preparative Scale Resolution of Enantiomers Enables Accelerated Drug Discovery and Development.

Leek H, Andersson S.

Molecules. 2017 Jan 18;22(1). pii: E158. doi: 10.3390/molecules22010158.

9.

Nano Secondary Ion Mass Spectrometry Imaging of Dopamine Distribution Across Nanometer Vesicles.

Lovrić J, Dunevall J, Larsson A, Ren L, Andersson S, Meibom A, Malmberg P, Kurczy ME, Ewing AG.

ACS Nano. 2017 Apr 25;11(4):3446-3455. doi: 10.1021/acsnano.6b07233. Epub 2016 Dec 27.

PMID:
27997789
10.

Application of neutral iridium(I) N-heterocyclic carbene complexes in ortho-directed hydrogen isotope exchange.

Cochrane AR, Irvine S, Kerr WJ, Reid M, Andersson S, Nilsson GN.

J Labelled Comp Radiopharm. 2013 Jul-Aug;56(9-10):451-4. doi: 10.1002/jlcr.3084. Epub 2013 Jul 19.

11.

Evaluation of the chiral recognition properties as well as the column performance of four chiral stationary phases based on cellulose (3,5-dimethylphenylcarbamate) by parallel HPLC and SFC.

Nelander H, Andersson S, Ohlén K.

J Chromatogr A. 2011 Dec 30;1218(52):9397-405. doi: 10.1016/j.chroma.2011.10.082. Epub 2011 Nov 2.

PMID:
22119140
12.

Highly active iridium(I) complexes for the selective hydrogenation of carbon-carbon multiple bonds.

Bennie LS, Fraser CJ, Irvine S, Kerr WJ, Andersson S, Nilsson GN.

Chem Commun (Camb). 2011 Nov 14;47(42):11653-5. doi: 10.1039/c1cc14367k. Epub 2011 Sep 29.

PMID:
21956242
13.

Making medicinal chemistry more effective--application of Lean Sigma to improve processes, speed and quality.

Andersson S, Armstrong A, Björe A, Bowker S, Chapman S, Davies R, Donald C, Egner B, Elebring T, Holmqvist S, Inghardt T, Johannesson P, Johansson M, Johnstone C, Kemmitt P, Kihlberg J, Korsgren P, Lemurell M, Moore J, Pettersson JA, Pointon H, Pontén F, Schofield P, Selmi N, Whittamore P.

Drug Discov Today. 2009 Jun;14(11-12):598-604. doi: 10.1016/j.drudis.2009.03.005. Epub 2009 Mar 11. Review.

PMID:
19508922
14.

Highly active iridium(I) complexes for catalytic hydrogen isotope exchange.

Brown JA, Irvine S, Kennedy AR, Kerr WJ, Andersson S, Nilsson GN.

Chem Commun (Camb). 2008 Mar 7;(9):1115-7. doi: 10.1039/b715938b. Epub 2008 Jan 3.

15.
16.

Preparative chiral chromatographic resolution of enantiomers in drug discovery.

Andersson S, Allenmark SG.

J Biochem Biophys Methods. 2002 Dec 31;54(1-3):11-23. Review.

PMID:
12543489
17.

Preparative resolution of drug racemates to study the chiroptical properties of their enantiomers.

Thunberg L, Andersson S, Allenmark S, Vessman J.

J Pharm Biomed Anal. 2002 Jan 15;27(3-4):431-9.

PMID:
11755744

Supplemental Content

Loading ...
Support Center